Fashion icon
XingImaging Opens State-of-the-Art Research Facility in New Haven, Connecticut
NEW HAVEN,Conn.,Jan. 13,2025-- XingImaging,a MITRO company,a leader in advanced research imaging and radiopharmaceutical services,is excited to announce the opening of its new state-of-the art resear
Redefining Charging: Anker Innovations Showcases Smart and Sustainable Solutions at CES and Unveils New Lineup in Taiwan
BELLEVUE,Wash.,Jan. 13,2025-- Anker Innovations,a global leader in mobile charging and consumer electronics,today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Sh
China Liberal Education Holdings Limited Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency
BEIJING,Jan. 13,2025--China Liberal Education Holdings Limited ("China Liberal" or the "Company") (NASDAQ:CLEU),a China-based company that provides technological consulting service
Redefining Charging: Anker Innovations Showcases Smart and Sustainable Solutions at CES
BELLEVUE,Wash.,Jan. 13,2025-- Anker Innovations,a global leader in mobile charging and consumer electronics,today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Sh
Scintimun® Commercialization Partnership with Curium Pharma
MELBOURNE,Australiaand LIÈGE,Belgium,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces that it has entered into an agreement with Curium Ph
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.
Gianna Lullume Baby Soother Device Officially Launches on Kickstarter
HONG KONG,Jan. 13,2025-- Gianna Lullume,an innovative brand committed to improving infant sleep and promoting family well-being,is proud to announce the official launch of its crowdfunding campaign on
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has entered into an asset purchase agreement with antibody
MLVision M5 Unveiled at CES 2025: Pioneering Innovation in Wearable Technology with the World's Lightest AI-Powered AR Glasses
LAS VEGAS,Jan. 11,2025-- AtCES 2025,MLVision has officially launched its groundbreaking MLVision M5,setting a new global standard for wearable technology. Weighing a mere 25.8 grams,the MLVision M5 is
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,similar to the preclinical stage KAT6 inhibitor (MEN2312) licens